A topical composition, comprising: an inflammatory management agent comprising lactose and/or milk protein, the inflammatory management agent being present in an amount of from about 0.01 wt. % to about 12.5 wt. % based on the weight of the topical composition; a vascular repair agent comprising palmitoyl glycine, the vascular repair agent being present in an amount of from about 0.01 wt. % to about 15 wt. % based on the weight of the topical composition; a neurogenic agent comprising an oligosaccharide, the neurogenic agent being present in an amount of from about 0.01 wt. % to about 22.5 wt. % based on the weight of the topical composition; a sebum suppression agent comprising Panthenyl Triacetate, farnesol and farnesyl acetate, the sebum suppression agent being present in an amount of from about 0.01 wt. % to about 25 wt. % based on the weight of the topical composition; and an exfoliating agent comprising at least one plant derived cysteine protease enzyme, the exfoliating agent being present in an amount of from about 0.01 wt. % to about 10 wt. % based on the weight of the topical composition.
一种外用组合物,包含:一种炎症控制剂,包含
乳糖和/或牛奶蛋白,该炎症控制剂的含量为约 0.01 wt.% ;血管修复剂,包括
棕榈酰甘氨酸,该血管修复剂的含量为约 0.01 wt.01 wt. %至约 22.5 wt. %,以外用组合物的重量为基数;一种皮脂
抑制剂,包括
三乙酸泛苯酯、
法呢醇和
乙酸法呢酯,以外用组合物的重量为基数,该皮脂
抑制剂的含量为约 0.01 wt.去角质剂包括至少一种植物提取的半胱
氨酸
蛋白酶,去角质剂的用量为约 0.01 重量百分比至约 10 重量百分比(基于外用组合物的重量)。